Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING PANCREATIC CANCER, INCLUDING TETRASPANIN-2 INHIBITOR AS ACTIVE INGREDIENT
Document Type and Number:
WIPO Patent Application WO/2020/197304
Kind Code:
A1
Abstract:
The present invention relates to a composition which is for preventing, ameliorating, or treating pancreatic cancer, and includes a tetraspanin-2 inhibitor as an active ingredient, and more specifically, to: a composition which is for preventing, ameliorating, or treating pancreatic cancer, and includes an inhibitor of the expression or activity of tetraspanin-2 (TSPAN-2) as an active ingredient; a method for selecting a therapeutic substance for treating pancreatic cancer, by measuring the expression level of TSPAN-2; and a method for providing information useful for diagnosing pancreatic cancer.

Inventors:
HWANG IN HU (KR)
Application Number:
PCT/KR2020/004160
Publication Date:
October 01, 2020
Filing Date:
March 27, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
HWANG JUNG HOO (KR)
International Classes:
A61K39/395; A23L33/17; A61K39/00; A61P35/00; C12Q1/6886; G01N33/50; G01N33/574
Foreign References:
JP2008535853A2008-09-04
KR101870963B12018-06-25
Other References:
WEBER, HEIKE ET AL.: "Hochauflosende Charakterisierung von DNA-Amplifikationen im Pankreaskarziom", ULM UNIVERSITY. PH.D. THESIS., 2009, pages 1 - 145, XP055743797
YASEEN, IBRAHIM H. ET AL.: "Tspan2: a tetraspanin protein involved in oJigodendrogenesis and cancer metastasis", BIOCHEMICAL SOCIETY TRANSACTIONS, vol. 45, 2017, pages 465 - 475, XP055736731, DOI: 10.1042/BST20160022
ZHANG, XIAOBO ET AL.: "TSPAN1 upregulates MMP2 to promote pancreatic cancer cell migration and invasion via PLCy", ONCOLOGY REPORTS, vol. 41, 30 January 2019 (2019-01-30), pages 21 17 - 2125
Attorney, Agent or Firm:
LEE, Hee Sook (KR)
Download PDF: